Ann: ATL1102 for DMD EMA PIP feedback and FDA regulatory progress, page-50

The Swiss McDuck invested all their $1.3B duck eggs into The American McDuck's GT program @Uboy

Uboy,
The American McDuck must have choked on its cornflakes reading the breaking news that 4D Molecular Therapeutics were handed back their eye disease gene therapy. The Swiss McDuck has spoken in emphatic terms, its ready to cut its losses.

Its most certainly time for American McDuck to reach for Plan B as unlucky randomisation and the more recent y'all know we should have used commercial representative process material. It would have been a nice line for Forrest Gump but I guess, the Swiss aren't known for their sense of humour.